Femoral Cannula Market

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.
When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.
Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.
Femoral Cannula Market contains market size and forecasts of Femoral Cannula in global, including the following market information:
Global Femoral Cannula Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Femoral Cannula Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Femoral Cannula companies in 2021 (%)
The global Femoral Cannula market was valued at 36 million in 2021 and is projected to reach US$ 52 million by 2028, at a CAGR of 5.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Unipolar Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Femoral Cannula include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Changzhou KangXin Medical Instruments Co., Ltd., Chalice Medical Ltd. and Xenios AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Femoral Cannula manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Femoral Cannula Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Femoral Cannula Market Segment Percentages, by Type, 2021 (%)
Unipolar
Bipolar
Global Femoral Cannula Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Femoral Cannula Market Segment Percentages, by Application, 2021 (%)
Traditional extracorporeal circulation surgery
Extracorporeal membrane oxygenation (ECMO)
Hemodialysis
Other
Global Femoral Cannula Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Femoral Cannula Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Femoral Cannula revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Femoral Cannula revenues share in global market, 2021 (%)
Key companies Femoral Cannula sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Femoral Cannula sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Changzhou KangXin Medical Instruments Co., Ltd.
Chalice Medical Ltd.
Xenios AG